Kugler Publications

12/06/2025

We changed the name of one of our journals to Artificial Intelligence in Vision and Ophthalmology (AIVO)! 🆕 (Formerly Modeling in Artificial Intelligence in Ophthalmology - MAIO)

AIVO is the first journal that provides a dedicated forum for interdisciplinary approaches that advance the safe, robust, and effective use of artificial intelligence (AI) in eye care.

26/03/2024

Hope to see you there!

What are the controversies around MIGS? Find out at the Asia Pacific Glaucoma Congress 2024! You can expect insights and learnings from our fellow scientists, clinicians, and other health practitioners.

Check out for more information here:
https://apgcongress.org/program/

20/03/2024

🤩 What a week! Thank you for being part of it!

This year we united globally and fought for a glaucoma-free world during the World Glaucoma Week! Between 10-16 March, people from 64 countries joined an impressive amount of over 600 activities all around the globe.👏

But our mission does not stop after . In order to achieve our goal of alerting everyone to have regular eye and optic nerve checks to detect glaucoma as early as possible, we will keep spreading awareness and insights about .

Curious to see what happened during this year's WGW edition? Take a look here 👉 https://www.worldglaucomaweek.org

01/03/2024

The relatively modest sample size of the European validation set elicits concerns.

✏️ Read comment by Xiulan Zhang & Deming Wang in IGR 23-4 http://ow.ly/8Kze30syj08

23/02/2024

The main limitation of the study is the generalizability of the results.

✏️ Read comment by Sasan Moghimi in IGR 23-4 http://ow.ly/GSUv30syj04

19/02/2024

IOP fluctuation was significantly greater postoperative, and the authors hypothesized that procedures aiming to reduce aqueous production may not blunt IOP fluctuation.

✏️ Read comment by Lisandro Sakata in IGR 23-4 http://ow.ly/WROI30syj07

16/02/2024

The 14-year number needed to treat to prevent one case of PAC was 12.4 compared to 44 at 6 years.

✏️ Read comment by Alanna James & Benjamin Xu in IGR 23-4 http://ow.ly/yZIq30syj03

12/02/2024

One additional topic that is pertinent to the entire space is the health economics of MIGS and cost implications of surgical choices.

✏️ Read comment by Ronald Fellman & Davinder S. Grover in IGR 23-4 http://ow.ly/pPKk30syj06

09/02/2024

Once the TM cells or Schlemn's canal endothelial cells are damaged and lose their function, the induction of MMP3 may not be effective.

✏️ Read comment by Makoto Aihara in IGR 23-4 http://ow.ly/mGkZ30syj02

05/02/2024

This study's results, could place the XEN gel stent as a viable less-invasive alternative to trabeculectomy, especially when efficacy, safety, and patients' quality of life are weighted against each other.

✏️ Read comment by Kaweh Mansouri in IGR 23-4 http://ow.ly/6CEX30syj05

02/02/2024

The proportion of eye drops successfully reaching the eye was actually lower using the nose-pivoted delivery device, though this was not statistically significant.

✏️ Read comment by Andrew Tatham & Celia Alcalde in IGR 23-4 http://ow.ly/lG6g30syj01

25/01/2024

It remains to be seen if this strategy can mediate consistent or neuroenhancement in human glaucoma.

✏️ Read comment by Keith Martin in IGR 23-4 http://ow.ly/cJ4630syj00